Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by State Street Corp

State Street Corp boosted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 80,856 shares of the medical instruments supplier’s stock after acquiring an additional 694 shares during the quarter. State Street Corp owned about 2.39% of Utah Medical Products worth $5,434,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Minerva Advisors LLC raised its position in Utah Medical Products by 461.8% in the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after acquiring an additional 34,794 shares in the last quarter. Brandes Investment Partners LP grew its holdings in Utah Medical Products by 66.2% in the second quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock valued at $7,789,000 after purchasing an additional 46,427 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in Utah Medical Products by 102.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 566 shares in the last quarter. American Century Companies Inc. lifted its stake in Utah Medical Products by 18.1% in the 2nd quarter. American Century Companies Inc. now owns 11,921 shares of the medical instruments supplier’s stock valued at $796,000 after buying an additional 1,830 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Utah Medical Products during the second quarter valued at $413,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $61.89 on Friday. The company has a market capitalization of $209.93 million, a price-to-earnings ratio of 14.49 and a beta of 0.08. The company’s fifty day moving average price is $64.41 and its two-hundred day moving average price is $66.36. Utah Medical Products, Inc. has a 12 month low of $60.39 and a 12 month high of $86.82.

Utah Medical Products Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Monday, December 16th will be paid a $0.305 dividend. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Monday, December 16th. Utah Medical Products’s payout ratio is presently 28.57%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.